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Prevalence of Subjects at a High or Very High Risk of Gastric 
Cancer in Japan
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Background/Aims: The presence of Helicobacter py-
lori  (H. pylori ) infection represents a high-risk state of 
gastric cancer, but the risk is even higher in gastric 
atrophy.  H. pylori stool antigen (HpSA) and serum 
pepsinogen (PG) tests are useful tools for screening 
present infection and gastric atrophy, respectively. To 
determine the prevalence of subjects at a high risk 
(HpSA＋ or PG＋) or very high risk (PG＋) of gastric 
cancer in Japan, we applied the two tests to a gen-
eral population. Methods: The subjects included 311 
volunteers. We used Meridian HpSA ELISA for the 
HpSA test and Pepsinogen RIA Beads for the PG 
test. PG I at ≤70  μg/L and I/II ratio of ≤3.0 were 
used as cutoffs for PG-test positivity. Results: 
Positivity rates in HpSA and PG tests significantly in-
creased with age in those younger than 60 years and 
in all age groups, respectively. The proportions of 
HpSA−/PG−  and HpSA＋/PG＋  subjects decreased 
and increased with age, respectively. A small pro-
portion of HpSA−/PG＋ subjects were older than 40 
years. The prevalence of subjects who were either 
HpSA＋ or PG＋ increased with age (＞50% of those 
older than 40 years). Half of the subjects older than 
60 years were PG＋.  Conclusions: In Japan, more 
than 50% of general population aged ≥40 years is at 
a high risk of gastric cancer, and half of the pop-
ulation aged ≥60 years is at a very high risk. (Gut 
and Liver 2009;3:95-100)
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INTRODUCTION
  It is established that Helicobacter pylori ( H. pylori) in-
fection is a high-risk state of gastric cancer,
1,2 and it is 
important to screen high risk subjects for gastric cancer 
in general population by using a certain H. pylori test. 
Anti-H.pylori antibody test is widely used to screen H. py-
lori infection, but it demonstrates past infection as well as 
present infection. On the other hand, H. pylori stool anti-
gen (HpSA) test predicts only present infection, and the 
test has a high sensitivity and specificity to screen pres-
ent  H. pylori infection.
3
  It is also established that gastric atrophy is a high risk 
state or a precursor lesion of gastric cancer.
4,5 Serum pep-
s i n o g e n  ( P G )  t e s t  i s  a  u s e f u l  t o o l  t o  s c r e e n  g a s t r i c  a t r o-
phy with or without endoscopic examination.
6
  Therefore, high-risk subjects for gastric cancer are rec-
ognized as those who have present H. pylori infection or 
gastric atrophy (HpSA＋ or PG＋), and very high risk 
subjects as those who have atrophy irrespective of present 
H. pylori infection (PG＋).
2
  To make a good strategy to screen high-risk subjects 
for gastric cancer in a population which has a high preva-
lence of gastric cancer such as Japanese or Korean, we ex-
amined sex and age distributions of HpSA and PG tests 
in a Japanese population. 
MATERIALS AND METHODS
1. Subjects
  The subjects were 333 volunteers who visited Health-
care Center of Social Insurance Shiga Hospital to undergo 
both HpSA and PG tests at annual health check in 2004. 
Twenty-two volunteers, who had undergone H. pylori 
eradication, are under treatment for peptic ulcer, had un-
dergone surgical operation for stomach, or had unknown 96   Gut and Liver, Vol. 3, No. 2, June 2009
Fig. 1. Age and sex distributions of the study subjects. Age 
distribution of the study subjects differed significantly with sex 
(chi-square test, p=0.000274).
Fig. 2. Positive rate in the HpSA test for each sex (A) and across all subjects (B) according to age groups. HpSA positivity differed
significantly with sex only in those aged 50-59 years (Yates’ corrected chi-square test, p=0.034). The positive rate in the HpSA test
was significantly correlated with age in males ＜60 years old and in all age groups in females (Spearman’s correlation test: rs=1,
p＜0.0001). The positive rate in the HpSA test was significantly correlated with age in combined males and females younger than
60 years (Spearman’s correlation test: rs=1, p＜0.0001).
medical history were excluded from the study.
2. HpSA and PG tests
  We used Meridian HpSA ELISA (TFB Inc., Tokyo, Japan/ 
Meridian Bioscience Inc., Cincinnati, OH, USA) to measure 
HpSA. Absorption was measured at 450/630 nm, and the 
results were evaluated as the followings. When ELISA 
value was 0.120 or above, the case was evaluated as 
HpSA-positive (HpSA＋). When ELISA value was below 
0.100, the case was evaluated as HpSA-negative (HpSA−). 
In case with intermediate result, the case was considered 
as indeterminate, and excluded from the study.
  For serum PG I and II, we used Pepsinogen RIA Beads 
I and II (Abbott Japan Co. Ltd., Tokyo, Japan). The result 
of PG test was interpreted by the value of PG I and the 
ratio of PG I/II. The criteria for positive PG test were de-
fined as the followings: both PG I was 70μg/L or below, 
and PG I/II ratio was 3.0 or below.
3. Statistical analyses
  Statistical analysis was performed using ystat2004.xls 
for Windows/Macintosh (Igaku Tosho Shuppan Co., Ltd, 
Tokyo, Japan). The Chi square test or Yates corrected Chi 
square test were used to compare the difference between 
sexes or age groups. Spearman’s correlation test was used 
to evaluate correlations between age groups and positive 
rates of HpSA or PG tests. Significance was evaluated 
with p value below 0.05 in two-tailed examination.
4. Ethics
  The study was approved by the Ethical Committee of 
Social Insurance Shiga Hospital.
RESULTS
  After exclusion of the subjects, 311 volunteers were in-
cluded in the study. The study population is shown in 
Fig. 1. The age distribution of the study subjects was sig-
nificantly different between sexes. Therefore the results 
were analyzed in each sex. 
  The results of HpSA test are shown in Fig. 2. There 
was significant difference in HpSA positivity between sex-
es in only 50s, but no difference in the other age groups. Yamaoka M, et al: High-Risk Subjects for Gastric Cancer in Japan   97
Fig. 3. Positive rate in the PG test for each sex (A) and across all subjects (B) according to age groups. PG positivity did not differ
significantly with sex (Yates’ corrected chi-square test). PG positivity was significantly correlated with age for each sex (A) and 
across all subjects (B) (Spearman’s correlation test: rs=1, p＜0.0001).
Fig. 4. Proportion of the results of HpSA and PG tests for 
males (A), females (B) and all subjects (C) according to age 
groups. The proportion of the two test results did not differ 
significantly with sex in each age group (Yates’ corrected 
chi-square test).98   Gut and Liver, Vol. 3, No. 2, June 2009
Positive rate of HpSA test increased with age in both sex-
es under 60s, but decreased in the older age in male 
whereas increased in female. Combined with both sexes, 
the positive rate of HpSA test significantly increased with 
age under 60s. 
  The results of PG test are shown in Fig. 3. The positive 
rate of PG test significantly increased with age in all age 
groups in both sexes. There was no significant difference 
in PG positivity between sexes. Combined with both sex-
es, the positive rate of PG test significantly increased 
with age in all age groups.
  The results of combination with HpSA and PG tests are 
shown in Fig. 4. There was no significant difference in 
the proportion of the two test results between sexes in 
e a c h  a g e  g r o u p .  C o m b i n e d  w i t h  b o t h  s e x e s ,  t h e  p r o -
portion of HpSA−/PG− subjects decreased with age. On 
the other hand, the proportion of HpSA＋/PG＋ subjects 
increased with age, whereas that of HpSA＋/PG−  sub-
jects increased until 40s, but then decreased in 50s and 
older. A small proportion of HpSA−/PG＋ subjects were 
detected in 40s and older. The prevalence of either HpSA＋ 
or PG＋ subjects increased with age. More than 50% sub-
jects aged 40 or older are either HpSA＋ or PG＋, and 
nearly 50% subjects in 60-70s were PG＋ (Fig. 4).
DISCUSSION
    The present study showed that the positive rate of 
HpSA test increased with age in both male and female, 
except for 60-70s in male. This age-dependent increase of 
HpSA positive rate was similar to the tendency of the 
positive rate of serum anti-H. pylori a n t i b o d y  i n  a  J a p a -
nese population reported by Asaka et al.
7 in 1992. There 
was a small difference in HpSA positive rate between sex-
e s in  on ly  50 s in  ou r stu d y . W e  can  n o t e v alu ate  if it is 
meaningful or not in the present study. It may be related 
t o  t h e  m a l e  p r e d o m i n a n c e  o f  g a s t r i c  d i s e a s e s  i n  5 0 s  i n  
Japanese.
8 The fact that the rate of HpSA-positive test did 
not increase in 60-70s in male may be the similar ten-
dency in Asaka’s study in which the rate of antibody- 
positive subjects born before 1950 did not increase. Com-
bined with both sexes, the positive rate of HpSA test sig-
nificantly increased with age under 60s in our study. The 
positive rate of HpSA test in our study was approximately 
60% in the subjects born before 1954 (50s or older), 
whereas the positive rate of H. pylori antibody in Asaka’s 
study was 70-80% in the subjects born before 1950. 
Because serum antibody is detected in the subjects who 
have been eradicated, the rate of positive antibody test 
m a y  b e  g r e a t e r  t h a n  t h a t  o f  p o s i t i v e  H p S A  t e s t  w h i c h  
shows present infection of H. pylori in the stomach. Thus 
our study indicated that the rate of present H. pylori in-
fection increased with age and the rate of present in-
fection in the subjects born before 1954 was approx-
imately 60%. Although HpSA test shows present infection 
of  H. pylori in the stomach, the test needs a measurable 
amount of H. pylori antigens in the stool. If there are only 
small amount of the bacteria in the stomach, the test 
could show a negative result. Therefore our results with 
HpSA test may be underestimated. This is one of the rea-
sons why the positive rate of HpSA test in our study was 
lower than that of antibody test in Asaka’s study.
  Our study also showed that the positive rate of PG test 
increased with age in both male and female. There was 
no significant difference between sexes. The rate of pos-
itive PG test in male did increase in 60-70s, indicating 
that increasing PG positive tendency continued over 50s 
in spite that the rate of present H. pylori infection did not 
i n c r e a s e .  I n  f e m a l e  t h e  p o s i t i v e  r a t e s  o f  H p S A  a n d  P G  
tests increased with age. Combined with both sexes, the 
positive rate of PG test increased with age. The positive 
rate of PG test increased later than the increase of the 
positive rate of HpSA test. Because PG test demonstrates 
gastric atrophy
6 and atrophy develops in subjects who 
have long-term infection of H. pylori in the stomach,
9-11 
our results of HpSA and PG test are consistent with the 
facts.
  In combination with both HpSA and PG tests, there was 
no significant difference between sexes in the proportion of 
the results of the two tests in each age group. Thus, com-
bined with both sexes, the proportion of HpSA−/PG− 
subjects decreased with age. This compartment of the sub-
jects reflects H. pylori-virgin subjects, indicating that 
younger people have less possibility of H. pylori infection 
in Japan. On the other hand the proportion of HpSA＋/ 
PG＋ subjects increased with age. This compartment re-
flects  H. pylori-infected subjects with gastric atrophy, in-
dicating that gastric atrophy increased with age. HpSA＋/ 
PG− subjects increased until 40s, but then decreased in 
50s and older. These tendencies of the two HpSA＋ com-
partments reflect that gastric atrophy developed from 
HpSA＋/PG−  subjects to HpSA＋/PG＋ subjects, and a 
half of the 50s and the majority of the 60-70s subjects 
with H. pylori infection had gotten atrophy, respectively. A 
small proportion of HpSA−/PG＋ subjects were detected 
in 40s and older. It is reported that long-term H. pylori 
infection causes gastric atrophy and intestinal meta-
plasia,
12 and the amount of the bacteria decreases in the 
individuals who have a large amount of intestinal meta-
plasia in the stomach.
13 Because intestinal metaplasia de-
velops in parallel to the development of gastric atrophy,
9 
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pylori had been rejected from the stomach or decreased 
below the measurable amount in some subjects in older 
ages due to progressed intestinal metaplasia with 
atrophy. It is reported that this compartment is the 
group that has the highest risk for gastric cancer,
2 so 
that we should not neglect the individuals in this 
compartment. In screening high risk subjects for gastric 
cancer with only HpSA test, the individuals with the 
highest risk could not be trapped. Thus PG test should 
be combined with HpSA test for screening high risk sub-
jects for gastric cancer.
  If we classified either HpSA＋ or PG＋ subjects as high- 
risk subjects for gastric cancer, the prevalence of high-risk 
subjects increased with age, and more than 50% subjects 
a g e d  4 0 s o r o ld e r a re  a t h ig h  ris k  in  J a p a n . I f  w e  c la s s i-
fied PG＋ subjects as very high-risk subjects for gastric 
cancer, nearly 50% subjects in 60-70s are at very high- 
risk in Japan. The combination of HpSA and PG test is 
one of the choices for screening and classifying high risk 
subjects for gastric cancer.
  However, in countries where the prevalence of H. py-
lori infection and gastric atrophy is high, such as in 
Japan, majority of the subjects in middle and high-aged 
populations show positive results by screening with the 
two tests. It may not be cost-effective to examine all 
the positive subjects with endoscopy. Therefore one 
more examination such as barium X-ray examination 
may be added for screening subjects who really need 
endoscopy.
  Recently, four methods for gastric cancer screening, ba-
rium X-ray examination, endoscopy, serum pepsinogen 
testing and Helicobacter pylori antibody testing, were eval-
uated by a systematic review in Japan.
14 According to the 
report, gastric cancer screening using barium X-ray ex-
amination is recommended for population-based screen-
ing, but the other methods were not recommended due 
to insufficient evidence. However, the report also sug-
gested that the high-risk subjects for gastric cancer could 
be identified with combination of H. pylori antibody and 
serum PG tests.
14 From the present study, by using HpSA 
and PG tests, we can also screen and identify those who 
are in high risk and very high risk for gastric cancer. Be-
cause eradication therapy is effective for prevention of 
gastric cancer in those who have atrophy in the stom-
ach,
15 and because HpSA test predicts current infection of 
H. pylori, this combination of HpSA and PG tests may 
give valuable information for eradication therapy to pre-
vent gastric cancer.
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